Relevant bibliographies by topics / Type 2 myocardial infarction

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Type 2 myocardial infarction'

Author: Grafiati
Published: 28 September 2022
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Type 2 myocardial infarction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Type 2 myocardial infarction"

1

Smer, Aiman, Ray W. Squires, Ahmed Aboeata, et al. "Type 2 Myocardial Infarction." Journal of Cardiopulmonary Rehabilitation and Prevention 41, no. 3 (2021): 147–52. http://dx.doi.org/10.1097/hcr.0000000000000550.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Radovanovic, Dragana, Thomas Pilgrim, Burkhardt Seifert, Philip Urban, Giovanni Pedrazzini, and Paul Erne. "Type 2 myocardial infarction." Journal of Cardiovascular Medicine 18, no. 5 (2017): 341–47. http://dx.doi.org/10.2459/jcm.0000000000000504.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dahhan, Ali. "Type 2 myocardial infarction." Journal of Cardiovascular Medicine 20, no. 8 (2019): 510–17. http://dx.doi.org/10.2459/jcm.0000000000000813.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nestelberger, Thomas, Jasper Boeddinghaus, and Christian Mueller. "Type 2 myocardial infarction." European Heart Journal 39, no. 42 (2018): 3825. http://dx.doi.org/10.1093/eurheartj/ehy535.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Collinson, P. O. "Type 2 myocardial infarction." Heart 101, no. 2 (2014): 89–90. http://dx.doi.org/10.1136/heartjnl-2014-306865.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sandoval, Yader, and Allan S. Jaffe. "Type 2 Myocardial Infarction." Journal of the American College of Cardiology 73, no. 14 (2019): 1846–60. http://dx.doi.org/10.1016/j.jacc.2019.02.018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sandoval, Yader, and Allan S. Jaffe. "Type 2 Myocardial Infarction." Journal of the American College of Cardiology 81, no. 2 (2023): 169–71. http://dx.doi.org/10.1016/j.jacc.2022.11.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Strömbäck, Ulrica, Åsa Engström, Robert Lundqvist, Dan Lundblad, and Irene Vikman. "The second myocardial infarction: Is there any difference in symptoms and prehospital delay compared to the first myocardial infarction?" European Journal of Cardiovascular Nursing 17, no. 7 (2018): 652–59. http://dx.doi.org/10.1177/1474515118777391.

Full text
Abstract:
Background: Knowledge is limited concerning the type of symptoms and the time from onset of symptoms to first medical contact at first and second myocardial infarction in the same patient. Aim: This study aimed to describe the type of symptoms and the time from onset of symptoms to first medical contact in first and second myocardial infarctions in men and women affected by two myocardial infarctions. Furthermore, the aim was to identify factors associated with prehospital delays ≥2 h at second myocardial infarction. Methods: A retrospective cohort study with 820 patients aged 31–74 years with
APA, Harvard, Vancouver, ISO, and other styles
9

London, Martin J. "Type 2 Perioperative Myocardial Infarction." Anesthesiology 128, no. 6 (2018): 1055–59. http://dx.doi.org/10.1097/aln.0000000000002153.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sandoval, Yader, and Kristian Thygesen. "Myocardial Infarction Type 2 and Myocardial Injury." Clinical Chemistry 63, no. 1 (2017): 101–7. http://dx.doi.org/10.1373/clinchem.2016.255521.

Full text
Abstract:
Abstract BACKGROUND The development and implementation of sensitive and high-sensitivity cardiac troponin assays has not only expedited the early ruling in and ruling out of acute myocardial infarction, but has also contributed to the identification of patients at risk for myocardial injury with necrosis, as confirmed by the presence of cardiac troponin concentrations above the 99th percentile. Myocardial injury with necrosis may occur either in the presence of overt ischemia from myocardial infarction, or in the absence of overt ischemia from myocardial injury accompanying other conditions. M
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Type 2 myocardial infarction"

1

Adachi, Yuichiro. "Angiotensin 2 type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice." Kyoto University, 2006. http://hdl.handle.net/2433/144310.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Putot, Alain. "Approche épidémiologique des infarctus du myocarde de type 2 : Etiologies, caractéristiques, traitements et pronostic." Thesis, Bourgogne Franche-Comté, 2020. http://www.theses.fr/2020UBFCI001.

Full text
Abstract:
Introduction : L’infarctus du myocarde (IDM) de type 2 a été récemment défini par un déséquilibre entre apports et besoins du myocarde en oxygène, en l’absence de processus athérothrombotique. L’objectif de ce travail était d’en décrire les principales étiologies, ainsi que les caractéristiques épidémiologiques, cliniques et pronostiques.Méthode : Les données des patients présentant un IDM de type 2 ont été recueillies à partir de l’observatoire des infarctus de Cote d’Or (RICO). Un travail complémentaire a analysé les données rétrospectives du service des urgences du Centre Hospitalier Univer
APA, Harvard, Vancouver, ISO, and other styles
3

Reed, Grant William. "Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Non-Cardiac Vascular Surgery." Case Western Reserve University School of Graduate Studies / OhioLINK, 2017. http://rave.ohiolink.edu/etdc/view?acc_num=case1491571890479287.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yao, Coffy-Akpolet. "Nouvelles approches épidémiologiques des infarctus du myocarde de type 2 : vers une prise en charge personnalisée." Electronic Thesis or Diss., Bourgogne Franche-Comté, 2023. http://www.theses.fr/2023UBFCI011.

Full text
Abstract:
Introduction : l’infarctus du myocarde (IDM) de type 2, qui résulte d’un déséquilibre entre les apports et les besoins en oxygène du myocarde en l’absence d’événement athéro-thrombotique, est une entité mal connue. L’objectif de ce travail était de préciser certains aspects épidémiologiques et diagnostiques de l’IDM de type 2, notamment la place de la maladie coronaire, et d’évaluer la pertinence clinique et pronostique d’une nouvelle classification des IDM proposée par de LemosMéthodes : A partir de la base de données de l’Observatoire des Infarctus de la Côte d’Or (RICO), nous avons analysé
APA, Harvard, Vancouver, ISO, and other styles
5

Grzesiak, Aleksandra [Verfasser]. "Angiotensin II type 2 receptor stimulation : a novel options of therapeutic interference with the renin-angiotensin system in myocardial infarction? / Aleksandra Grzesiak." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2014. http://d-nb.info/1052529879/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lauer, Dilyara [Verfasser]. "Prevention of cardiac remodeling after experimental myocardial infarction. Role of the angiotensin II type 2 receptor stimulation and modulation of MMP/TIMP axis / Dilyara Lauer." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2016. http://d-nb.info/1119803527/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Davidson, Melissa Anne. "A Pharmacovigilance Approach for Assessing Cardiovascular, Osteological, and Carcinogenic Risk Associated with Thiazolidinedione Drugs Used in the Treatment of Type 2 Diabetes Mellitus." Thesis, Université d'Ottawa / University of Ottawa, 2018. http://hdl.handle.net/10393/38062.

Full text
Abstract:
Diabetes is a chronic and debilitating disease that affects nearly half a billion people worldwide with the vast majority of diabetics suffering from Type 2 diabetes mellitus (T2DM), a disease characterized by insulin insensitivity that often requires pharmacotherapy to effectively maintain target blood sugar levels. The thiazolidinedione (TZD) class of drugs consists of oral hypoglycaemic agents used alone or in combination with other antidiabetic drugs to treat T2DM. The drugs within this class, which include rosiglitazone and pioglitazone, were originally heralded as providing novel first a
APA, Harvard, Vancouver, ISO, and other styles
8

Wu, Chiung-Jung. "Promoting self-management for patients with type 2 diabetes following a critical cardiac event." Thesis, Queensland University of Technology, 2007. https://eprints.qut.edu.au/16465/1/Chiung-Jung_Wu_Thesis.pdf.

Full text
Abstract:
Type 2 diabetes is a global health problem. Evidence indicates that type 2 diabetes can lead to serious complications, such as a cardiac event, which usually require critical nursing care. Patients with type 2 diabetes and with a history of cardiac disease are at greater risk of a further cardiac event requiring readmission to hospital. Evidence indicates that improved diabetes management assists patients with type 2 diabetes to manage their condition efficiently, reduces risks of a further cardiac event, and therefore reduces hospitalisations. However, there is limited information foun
APA, Harvard, Vancouver, ISO, and other styles
9

Wu, Chiung-Jung. "Promoting self-management for patients with type 2 diabetes following a critical cardiac event." Queensland University of Technology, 2007. http://eprints.qut.edu.au/16465/.

Full text
Abstract:
Type 2 diabetes is a global health problem. Evidence indicates that type 2 diabetes can lead to serious complications, such as a cardiac event, which usually require critical nursing care. Patients with type 2 diabetes and with a history of cardiac disease are at greater risk of a further cardiac event requiring readmission to hospital. Evidence indicates that improved diabetes management assists patients with type 2 diabetes to manage their condition efficiently, reduces risks of a further cardiac event, and therefore reduces hospitalisations. However, there is limited information foun
APA, Harvard, Vancouver, ISO, and other styles
10

Curato, Caterina. "Identification of a non-cytotoxic and IL-10- producing CD8+AT2R+ T lymphocyte population in response to ischemic heart injury." Doctoral thesis, Humboldt-Universität zu Berlin, Mathematisch-Naturwissenschaftliche Fakultät I, 2011. http://dx.doi.org/10.18452/16362.

Full text
Abstract:
Neuere Untersuchungen legen eine kardioprotektive Rolle für den Angiotensin AT2-Rezeptor nahe, welcher die Postinfarkt-Entzündungsreaktion vermindert, wobei der zelluläre Mechanismus noch wenig verstanden ist. Das Ziel dieser Arbeit war es deshalb, die potentielle Rolle des AT2-Rezeptors in der zellulären Immunantwort auf ischemische Herzverletzungen zu ergründen. Sieben Tage nach myokardialem Infarkt in Ratten wurde der AT2-Rezeptor mittels Immunfluoreszenzfärbung von Gewebeschnitten in einer CD8 T-Zellfraktion detektiert, die das Peri-Infarkt-Myokard infiltiert hatte. Wir haben eine Methode
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Type 2 myocardial infarction"

1

Müller-Schreiber, Sabine Christine. Myokardinfarkt und Leistungsmotivation. P. Lang, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Inoue, Michitoshi. Kokuritsu byōin, ryōyōjo ni okeru konpyūta nettowāku o mochiita shinkin kōsoku no 1-ji, 2-ji yobō to kosuto benefitto ni kansuru tashisetsu maemuki kenkyū: Heisei 12-nendo sōkatsu kenkyū hōkokusho. s.n.], 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gross, Dawn H. Progressive muscular relaxation and rational-emotive therapy during the rehabilitation of survivors of first episode myocardial infarction classified as type A. UMIST, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

A, Raineri, Leachman Robert D, Kellermann Jan J, and International School of Cardiology (4th : 1986 : Ettore Majorana Centre for Scientific Culture), eds. The State and future directions of acute myocardial infarction: Proceedings of a course held at the International School of Medical Sciences, Ettore Majorana Centre for Scientific Culture, Italy, 2-7 April 1986. Harwood Academic Publishers, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

King, Stephen. Brennen muß Salem. 2nd ed. Heyne, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

King, Stephen. El misterio de Salem's Lot. Plaza & Janés, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

King, Stephen. 'Salem's lot. Plume, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

King, Stephen. 'Salem's lot. G.K. Hall, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

King, Stephen. El misterio de Salem’s Lot. Plaza & Janés, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

King, Stephen. ’Salem’s Lot. Pocket Books, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Type 2 myocardial infarction"

1

Hanefeld, M., S. Fischer, J. Schulze, U. Julius, U. Schwanebeck, and H. Schmechel. "Hypertriglyceridaemia (HTG) as independent risk factor for myocardial infarction in type 2 diabetes: The Diabetes Intervention Study." In Diätetik und Arteriosklerose. Vieweg+Teubner Verlag, 1993. http://dx.doi.org/10.1007/978-3-663-01942-8_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Alpert, Joseph S., and Allan S. Jaffe. "What Is a Type 2 Myocardial Infarction: How Is It Recognized and What Should One Do to Establish That Diagnosis?" In Cardiac Biomarkers. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-42982-3_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Roth, Elliot J. "Myocardial Infarction." In Encyclopedia of Clinical Neuropsychology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2192-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Nandave, Mukesh. "Myocardial Infarction." In Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors in Heart Failure. Springer Nature Singapore, 2024. http://dx.doi.org/10.1007/978-981-97-7568-2_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Lowenstein, Nancy A., and Patricia Halloran. "Adam: Myocardial Infarction." In Case Studies Through the Health Care Continuum, 2nd ed. Routledge, 2024. http://dx.doi.org/10.4324/9781003522843-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ye, Siqin. "Acute Myocardial Infarction." In Encyclopedia of Behavioral Medicine. Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4614-6439-6_1243-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Neskovic, Aleksandar N., Leonardo Bolognese, and Michael H. Picard. "Echocardiography in acute myocardial infarction." In Emergency Echocardiography, 3rd ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003245407-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Neuhaus, K. L. "Recombinant Tissue-Type Plasminogen Activator in the Treatment of Myocardial Infarction." In Reperfusion and Revascularization in Acute Myocardial Infarction. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-83544-5_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Stump, David. "Pro-urokinase and tissue-type plasminogen activator." In Facts and Hopes in Thrombolysis in Acute Myocardial Infarction. Steinkopff, 1986. http://dx.doi.org/10.1007/978-3-662-07174-8_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Collen, Désiré, and H. Roger Lijnen. "Tissue-type plasminogen activator: helping patients with acute myocardial infarction." In Recombinant Protein Drugs. Birkhäuser Basel, 2001. http://dx.doi.org/10.1007/978-3-0348-8346-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Type 2 myocardial infarction"

1

Hung, John, Andreas Roos, Erik Kadesjo, et al. "23 Performance of the grace 2.0 score in patients with type 1 and type 2 myocardial infarction." In Abstracts from the British Cardiovascular Society Annual Conference 2020. BMJ Publishing Group Ltd and British Cardiovascular Society, 2020. http://dx.doi.org/10.1136/heartjnl-2020-bcs.23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Taggart, Caelan, Anton Gard, Anda Bularga, et al. "48 Outcomes following acute myocardial injury and type 2 myocardial infarction in patients with and without coronary artery disease." In British Cardiovascular Society Annual Conference, ‘100 years of Cardiology’, 6–8 June 2022. BMJ Publishing Group Ltd and British Cardiovascular Society, 2022. http://dx.doi.org/10.1136/heartjnl-2022-bcs.48.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wereski, Ryan, John Hung, Anoop SV Shah, et al. "28 Probability of coronary disease and clinical outcomes in patients with type 2 myocardial infarction." In Abstracts from the British Cardiovascular Society Annual Conference 2020. BMJ Publishing Group Ltd and British Cardiovascular Society, 2020. http://dx.doi.org/10.1136/heartjnl-2020-bcs.28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Koteliukh, Mariia. "CONTENTS OF ENERGY HOMEOSTASY INDICATORS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH CONCOMITANT TYPE 2 DIABETES MELLITUS." In SCIENTIFIC PRACTICE: MODERN AND CLASSICAL RESEARCH METHODS, chair Pavlo Kravchun. European Scientific Platform, 2021. http://dx.doi.org/10.36074/logos-26.02.2021.v3.13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bularga, Anda, Atul Anand, Fiona E. Strachan, et al. "19 The mechanism of supply-demand imbalance and clinical outcomes in patients with type 2 myocardial infarction." In Abstracts from the British Cardiovascular Society Annual Conference 2020. BMJ Publishing Group Ltd and British Cardiovascular Society, 2020. http://dx.doi.org/10.1136/heartjnl-2020-bcs.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Taggart, Caelan, Amy Ferry, Bertil Lindahl, et al. "60 Consensus on the diagnosis and management of patients with type 2 myocardial infarction: an international delphi study." In British Cardiovascular Society Annual Conference, ‘Future-proofing Cardiology for the next 10 years’, 5–7 June 2023. BMJ Publishing Group Ltd and British Cardiovascular Society, 2023. http://dx.doi.org/10.1136/heartjnl-2023-bcs.60.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bode, C., F. Schwarz, G. Schuler, R. Zimmermann, and W. Kubler. "INTRAVENOUS THROMBOLYTIC THERAPY WITH SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643574.

Full text
Abstract:
Seventeen patients with acute myocardial infarction were treated with heparin combined with intravenous single-chain urokinase-type plasminogen activator (scu-PA),obtained from transformed human kidney cells. 4 patients in group I and 13 patients in group II received a bolus of 4 mg and 7-5 mg followed by an infusion of 11 mg and 40.5 mg over 60 minutes, respectively. Thrombolysis was achieved in no patient of group I during intravenous infusion of scu-PA, however, upon subsequent intracoronary infusion of 250000 IE streptokinase, reperfusion could be established in two out of three patients.
APA, Harvard, Vancouver, ISO, and other styles
8

Stump, D. C., E. J. Topol, R. Califf, A. B. Chen, A. Hopkins, and A. D. Collen. "RESULTS OF COAGULATION - FIBRINOLYSIS ANALYSES IN 386 PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR (rt-PA) (TAMI TRIAL)." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643746.

Full text
Abstract:
Three hundred eighty-six patients with acute myocardial infarction received up to 150 mg rt-PA (single chain) IV either over 8 h (60mg over 1 h, 20 mg/h for 2 h,10 mg/h for 5 h)(173 pts) or over"5h(1 mg/kg over 1 h, remainder over 4 h) (213 pts),before randomization to early or late angioplasty. Blood was collected on a lyophilized mixture of citrate and the t-PA inhibitor D-Phe-Pro-Arg-CH2C1 (PPACK), to maximally prevent in vitro fibrinolytic activation and concomitant fibrinogen degradation. The plasma rt-PA level increased to 2.4±2.0 /μg/ml(mean +SD)and 1.7 ±1.3 /μg/ml after 3h and to 1.0 ±
APA, Harvard, Vancouver, ISO, and other styles
9

Altunina, N. V. "Effect of alpha-lipoic acid combined with zinc sulfate on daily profile of blood pressure in patients with type 2 diabetes mellitus who have had non-Q-myocardial infarction." In NEW TRENDS AND UNRESOLVED ISSUES OF PREVENTIVE AND CLINICAL MEDICINE. Baltija Publishing, 2020. http://dx.doi.org/10.30525/978-9934-588-81-5-1.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fleetwood, K., S. Wild, D. Smith, et al. "OP73 The impact of major mental illness on risk of stroke and myocardial infarction in people with type 2 diabetes in scotland: an analysis of routinely collected health data." In Society for Social Medicine 62nd Annual Scientific Meeting, Hosted by the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, 5–7 September 2018. BMJ Publishing Group Ltd, 2018. http://dx.doi.org/10.1136/jech-2018-ssmabstracts.72.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Type 2 myocardial infarction"

1

Deo, Salil, David McAllister, Naveed Sattar, and Jill Pell. The time-varying cardiovascular benefits of glucagon like peptide-1 agonist (GLP-RA)therapy in patients with type 2 diabetes mellitus: A meta-analysis of multinational randomized trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.7.0097.

Full text
Abstract:
Review question / Objective: P - patients with type 2 diabetes melllitus already receiving routine medical therapy; I - patients receiving glucagon like peptide 1 receptor agonist (GLP1 receptor agonist) therapy (semaglutide, dulaglutide, liraglutide, exenatide, lixisenatide, efpeglenatide, abiglutide); C - patients receiving standard therapy for diabetes mellitus but not receiving GLP1 agonist therapy; O - composite end point as per invididual trial, cardiovascular mortality, all-cause mortality, myocardial infarction, stoke. Condition being studied: Type 2 diabetes mellitus. Study designs to
APA, Harvard, Vancouver, ISO, and other styles
2

Li, Peng, Na jia, Bing Liu, and Qing He. Effect of cardiac shock wave therapy on adverse cardiovascular event for patients with coronary artery disease: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.1.0103.

Full text
Abstract:
Review question / Objective: We have previously demonstrated that cardiac shock wave therapy (CSWT) effectively improves myocardial perfusion in patients with coronary artery disease (CAD). In this study, we want to address whether CSWT could decrease the risk of adverse cardiovascular events in CAD patients unsuitable for revascularization. Eligibility criteria: Trials are considered eligible if they meet these criteria: (1) patients included are diagnosed as refractory angina or ischemic heart failure; (2) the study i a randomized controlled trial (RCT) or a prospective cohort study; (3) int
APA, Harvard, Vancouver, ISO, and other styles
3

Sosa Munguía, Paulina del Carmen, Verónica Ajelet Vargaz Guadarrama, Marcial Sánchez Tecuatl, Mario Garcia Carrasco, Francesco Moccia, and Roberto Berra-Romani. Diabetes mellitus alters intracellular calcium homeostasis in vascular endothelial cells: a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.5.0104.

Full text
Abstract:
Review question / Objective: What are the effects of diabetes mellitus on the calcium homeostasis in vascular endothelial cells? -To describe the effects of diabetes on the mechanisms that regulate intracellular calcium; -To describe other molecules/mechanisms that alters intracellular Ca2+ homeostasis. Condition being studied: Diabetes mellitus is a pathology with a high incidence in the population, characterized by an increase in blood glucose. People with diabetes are 2-4 times more likely to suffer from a cardiovascular complication, such as total or partial loss of sight, myocardial infar
APA, Harvard, Vancouver, ISO, and other styles
4

liao, xiaoqian, xingyu fan, ziyi wang, shumin huang, and zhixi hu. Prognostic value of heart-type fatty acid binding protein in heart failure: a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0126.

Full text
Abstract:
Review question / Objective: (1)Can heart type fatty acid binding protein effectively predict the prognosis of patients with heart failure? (2)Is high expression of ear type fat acid binding protein associated with poor clinical outcomes in patients with heart failure? Condition being studied: Heart-type fatty acid binding protein (H-FABP) mainly exists in cardiomyocytes and is a potential biomarker of myocardial injury.However, the adverse consequences of heart failure have not been fully analyzed.Therefore, the purpose of this study was to comprehensively evaluate the correlation between H-F
APA, Harvard, Vancouver, ISO, and other styles
5

Newman-Toker, David E., Susan M. Peterson, Shervin Badihian, et al. Diagnostic Errors in the Emergency Department: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), 2022. http://dx.doi.org/10.23970/ahrqepccer258.

Full text
Abstract:
Objectives. Diagnostic errors are a known patient safety concern across all clinical settings, including the emergency department (ED). We conducted a systematic review to determine the most frequent diseases and clinical presentations associated with diagnostic errors (and resulting harms) in the ED, measure error and harm frequency, as well as assess causal factors. Methods. We searched PubMed®, Cumulative Index to Nursing and Allied Health Literature (CINAHL®), and Embase® from January 2000 through September 2021. We included research studies and targeted grey literature reporting diagnosti
APA, Harvard, Vancouver, ISO, and other styles
6

McCausland, Rachel, Joann Fontanarosa, and Ravi Patel. Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review. Agency for Healthcare Research and Quality (AHRQ), 2023. http://dx.doi.org/10.23970/ahrqepcrapidcoronary.

Full text
Abstract:
Aims. There is uncertainty around the optimal role of percutaneous coronary intervention (PCI) for management of chronic coronary syndrome, specifically when patients have disease in multiple coronary vessels and disease in the proximal portion of the left anterior descending coronary artery. This uncertainty was reflected in 2021 guidance from the American College of Cardiology (ACC)/American Heart Association (AHA) on coronary artery revascularization. The Agency for Healthcare Research and Quality has commissioned this rapid response literature review to meet a Congressional request for a s
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Type 2 myocardial infarction' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography